Posted on 3/8/2021
Viasonix receives FDA approval for Dolphin/XF, launches international sales of breakthrough Transcranial Doppler Robot
Viasonix is proud to announce the reception of FDA approval and the launch of its IP-protected Dolphin/XF, a new Transcranial Doppler (TCD) Robot with sophisticated algorithms that will dramatically impact the TCD market. The Dolphin/XF Robot connects to any of the advanced Dolphin TCD models to automatically assist the users in quickly obtaining bilateral cerebral bloo...